Larissa Wenning

Statistics

Publications

Citations

3.6K

H-Index

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Covance (United States)

Siriraj Hospital

State University of New York

Larissa Wenning is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, antiretroviral therapy, and antiviral therapy.

ORCID

Publications per year

1995–2022

Publications

Rapid and Durable Antiretroviral Effect of the HIV-1 Integrase Inhibitor Raltegravir as Part of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection

Martin Markowitz, Bach‐Yen Nguyen, Eduardo Gotuzzo et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 407 citations

Medicine, Pharmacology, Pharmacotherapy +17

Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected Individuals

Martin Markowitz, Javier O Morales-Ramirez, Bach‐Yen Nguyen et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 366 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Modeling pO2 Distributions in the Bone Marrow Hematopoietic Compartment. II. Modified Kroghian Models

Dominic C. Chow, Larissa Wenning, William M. Miller et al. · Biophysical Journal · 2001 · 300 citations · Full text

Life Sciences, Hematology, Physiology +8

Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme

Kelem Kassahun, Ian McIntosh, Donghui Cui et al. · Drug Metabolism and Disposition · 2007 · 275 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Modeling pO2 Distributions in the Bone Marrow Hematopoietic Compartment. I. Krogh's Model

Dominic C. Chow, Larissa Wenning, William M. Miller et al. · Biophysical Journal · 2001 · 241 citations · Full text

Life Sciences, Hematology, Physiology +6

1–5 of 51